Radiological diagnostics of multiple myeloma [Radiologische Diagnostik des multiplen Myeloms]

被引:0
|
作者
D'Anastasi M. [1 ]
Grandl S. [1 ]
Reiser M.F. [1 ]
Baur-Melnyk A. [1 ]
机构
[1] Institut für Klinische Radiologie, Klinikum der Ludwig-Maximilians-Universität München, 81377 München, Campus Großhadern
来源
Der Radiologe | 2014年 / 54卷 / 6期
关键词
Imaging; Magnetic resonance imaging; Plasmocytoma; Positron emission tomography computed tomography; Whole body computed tomography;
D O I
10.1007/s00117-013-2628-9
中图分类号
学科分类号
摘要
Clinical/methodical issue: Robust and reliable imaging methods are required to estimate the skeletal tumor load in multiple myeloma, as well as for the diagnosis of extraskeletal manifestations. Imaging also plays an essential role in the assessment of fracture risk and of vertebral fractures. Standard radiological methods: The conventional skeletal survey has been the gold standard in the imaging of multiple myeloma for many years. Methodical innovations: Other modalities which have been investigated and are in use are whole-body computed tomography (WBCT), 18F-fluorodeoxyglucose positron emission tomography computed tomography (FDG PET-CT) and whole-body magnetic resonance imaging (WBMRI). These techniques are able to depict both mineralized bone and the bone marrow with a high sensitivity for myeloma lesions. Performance: Several studies have shown that cross-sectional imaging is superior to the skeletal survey in the detection of myeloma lesions and WBMRI has been shown to be significantly more sensitive than WBCT for the detection of focal myeloma lesions as well as for diffuse infiltration. The FDG PET-CT technique has a sensitivity comparable to WBMRI. Achievements: Due to the higher sensitivity in the detection of myeloma lesions WBCT and WBMRI should replace the skeletal survey. Practical recommendations: A WBCT should be performed if there is suspicion of multiple myeloma. If no focal lesions are found WBMRI or at least MRI of the spine and pelvis should be additionally performed if available. If WBMRI has been initially performed and focal lesions are present, an additional WBCT may be performed to assess the extent of bone destruction and fracture risk. In cases of monoclonal gammopathy of undetermined significance (MGUS), solitary and smoldering myeloma, a WBMRI, if available, should be performed in addition to WBCT. © 2014 Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:556 / 563
页数:7
相关论文
共 50 条
  • [1] Biology of multiple myeloma [Biologie des multiplen Myeloms]
    Hose D.
    Seckinger A.
    Der Onkologe, 2014, 20 (3): : 208 - 216
  • [2] Biology of multiple myeloma [Biologie des multiplen myeloms]
    Drach J.
    Der Onkologe, 2004, 10 (8): : 801 - 808
  • [3] The treatment of multiple myeloma [Die behandlung des multiplen myeloms]
    Ludwig H.
    Der Onkologe, 1999, 5 (4): : 307 - 314
  • [4] PET-CT for nuclear medicine diagnostics of multiple myeloma [PET-CT in der nuklearmedizinischen Diagnostik des multiplen Myeloms]
    Dimitrakopoulou-Strauss A.
    Der Radiologe, 2014, 54 (6): : 564 - 571
  • [5] Conventional treatment of multiple myeloma [Konventionelle therapie des multiplen myeloms]
    Ludwig H.
    Strasser-Weippl K.
    Zojer N.
    Der Onkologe, 2004, 10 (8): : 820 - 831
  • [6] Radiological diagnostics in CUP syndrome [Radiologische Diagnostik des CUP-Syndroms]
    Kazmierczak P.M.
    Nikolaou K.
    Rominger A.
    Graser A.
    Reiser M.F.
    Cyran C.C.
    Der Radiologe, 2014, 54 (2): : 117 - 123
  • [7] Biologie des multiplen Myeloms
    J. Drach
    Der Onkologe, 1999, 5 (4): : 286 - 289
  • [8] Faktenblatt: Epidemiologie des multiplen Myeloms in DeutschlandFact sheet: epidemiology of multiple myeloma in Germany
    Christine Eisfeld
    Frederik Peters
    Annemarie Schultz
    Andreas Stang
    Hiltraud Kajüter
    Die Onkologie, 2025, 31 (4) : 352 - 357
  • [9] Immuntherapien des multiplen Myeloms
    Kadel, Sofie-Katrin
    Rasche, Leo
    ONKOLOGIE, 2025, : 406 - 415